The University of Chicago Header Logo

Connection

Daniel Shevrin to TOR Serine-Threonine Kinases

Back to Details
This is a "connection" page, showing publications Daniel Shevrin has written about TOR Serine-Threonine Kinases.
Daniel Shevrin
Connection Strength
0.029
TOR Serine-Threonine Kinases
  1. Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study. Urology. 2015 Dec; 86(6):1206-11.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.